URGN•benzinga•
Oppenheimer Maintains Outperform on UroGen Pharma, Lowers Price Target to $10
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 3, 2025 by benzinga